openPR Logo
Press release

Companion Diagnostics Market to Witness Steady Growth at 32.3% CAGR During 2016 - 2021

Companion Diagnostics Market to Witness Steady Growth at 32.3%

Researchmoz added Most up-to-date research on "Companion Diagnostics: Technologies and Markets" to its huge collection of research reports.

Report Highlights
The global market for companion diagnostics reached nearly $3.2 billion in 2015. This market is expected to increase from $4.3 billion in 2016 to nearly $17.6 billion in 2021 at a compound annual growth rate (CAGR) of 32.3% for 2016-2021.

Report Includes

An overview of the market for companion diagnostics, including existing products on the market and detailed analysis of the competitive environments.
Analyses of market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
Examination of the current state of the industry, new technologies in assay development, and potential novel commercial venues in this area of the healthcare industry.
Identification of major commercial sectors in companion diagnostics: oncology related products vs. cardiovascular diseases and other segments.
Profiles of major players as well as a list of current companies that have new companion diagnostics products in development.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1377117

Report Scope

The scope of the report encompasses the major types of diagnostics technologies that have been used, the various industry structures such as the lab developed tests (LDTs) sector, and the major applications being commercialized and developed by a wide range of company types. It analyzes current market status, examines future market drivers and presents forecasts of growth over the next five years. Technology developments, including the latest trends, are discussed.

Chapter 1 INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
SCOPE OF REPORT
INTENDED AUDIENCE
INFORMATION SOURCES
ANALYST'S CREDENTIALS
RELATED REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
Chapter 2 SUMMARY
Chapter 3 PERSONALIZED MEDICINE OVERVIEW
Chapter 4 CDX APPLICATIONS OTHER THAN CANCER
Chapter 5 FDA DESIGNATED CDXCANCER
Chapter 6 CURRENT TECHNIQUES, TECHNOLOGIES AND MARKET STRUCTURES
Chapter 7 NOT FDA REQUIRED
Chapter 8 EMERGING LIQUID BIOPSY MARKET
Chapter 9 UNIVERSAL CDX
Chapter 10 FUTURE APPLICATIONS: CARDIOVASCULAR AND METABOLIC DISEASE
Chapter 11 REPRESENTATIVE ACQUISITIONS AND COMPANY PROFILES
OVERVIEW
ONCOLOGY AS MAJOR DRIVER
COMPANION DIAGNOSTICS OVERVIEW

Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/companion-diagnostics-technologies-and-markets-report.html/toc

GENERAL APPLICATION CATEGORIES
FDA DEFINITION
FDA CLEARED (510K) AND APPROVED (PMA) MARKET
BEYOND "FDA DESIGNATED CDX"
PHARMACEUTICAL-DIAGNOSTIC DEALS
COMPANY TYPES
HISTORY OF COMPANION DIAGNOSTICS
REGULATORY ASPECTS
KEY COMPANIES
CANCER MARKET SEGMENT
TECHNOLOGIES OVERVIEW
REIMBURSEMENT
DRIVERS OF ADOPTION
BARRIERS TO ADOPTION
COST OF CDX DEVELOPMENT
CDX REGULATORY ISSUES
2015 PRECISION MEDICINE INITIATIVE
POTENTIAL FOR PERSONALIZED MEDICINE
Continue...

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us

Follow us on LinkedIn @ http://bit.ly/1TBmnVG

Follow me on @ https://marketsizeinfo.blogspot.in/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Companion Diagnostics Market to Witness Steady Growth at 32.3% CAGR During 2016 - 2021 here

News-ID: 1459715 • Views:

More Releases from Companion Diagnostics Market

Companion Diagnostics Market Size 2020-26, QIAGEN, Agilent, BioMerieux
Companion Diagnostics Market Size 2020-26, QIAGEN, Agilent, BioMerieux
The latest study on the Global Companion Diagnostics market report represents a deep appraisal of the international industry. The research report on the worldwide Companion Diagnostics market 2020-2026 sheds light on qualitative as well as quantitative insights, historical Companion Diagnostics industry status and authorized projection related to the Companion Diagnostics market size. Each and every segment exhibited in this report are discovered through verifiable research methods and techniques. It also
Companion Diagnostics Market - Analysis And Forecast (2016-2024): Market Shares And Strategies Of Key Players
Companion Diagnostics Market - Analysis And Forecast (2016-2024): Market Shares …
Companion diagnostic (CDx) is a diagnostic tool used to determine the suitability of a drug therapy to the patient. It has become a critical part of targeted cancer therapy that allows for development of personalized therapy can be developed and administered to the patient. Whole blood samples, tissues samples, or buccal samples are collected and tested for diagnosis and identification of targeted disease biomarker. CDx is usually utilized in identifying
CMI Releases New Report on the Companion Diagnostics Market,2017-2024.
CMI Releases New Report on the Companion Diagnostics Market,2017-2024.
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic
COMPANION DIAGNOSTICS MARKET TO SURPASS US$ 5.0 BILLION BY 2024 : CMI
COMPANION DIAGNOSTICS MARKET TO SURPASS US$ 5.0 BILLION BY 2024 : CMI
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic

All 5 Releases


More Releases for Chapter

SISA’s Dharshan Shanthamurthy Addresses ISACA Bangalore Chapter
Bengaluru May 1, 2019: SISA Information Security, a global payment security specialist, announced that Mr. Dharshan Shanthamurthy, Founder and CEO, SISA Information Security recently delivered an informative address on payment security to the ISACA Bangalore Chapter on Saturday 27th April 2019. Mr. Shanthamurthy drew from his own first hand observations of the payment industry, garnered over the years. He spoke about emerging trends in the payments industry, including some of
Chapter 4 of 'Meri Pyaari Bindu'
While the first three chapters of Ayushmann Khurrana and Parineeti Chopra starrer 'Meri Pyari Bindu' tickled our funny bones, the fourth chapter has already made its way. Parineeti shared it on her Twitter handle by tweeting, "So easy to scandalise Abhi's MOM!!! Hahhahahaha here is Chapter 4 :) Bindu v/s Ma 😎😎😎 #MeriPyaariBindu." The chapter 4 shows Tom and Jerry equation between Bindu and Abhimanyu's mom. Bindu, who is Abhi's neighbour
AFEA Welcomes New Chapter President
Leader in Financial Literacy Continues to Expand The American Financial Education Alliance is dedicated to providing financial education and increasing financial literacy within communities all over the country. Today, the Board of Directors has chosen to continue to do just that, by unanimously voting in Robert Wolf as the new Chapter President of AFEA’s Orange, CA Chapter. With the addition of Robert Wolf as the new Chapter President, AFEA is expanding
AFEA Welcomes New Chapter President
The American Financial Education Alliance is dedicated to providing financial education and increasing financial literacy within communities all over the country. Today, the Board of Directors has chosen to continue to do just that, by unanimously voting in Anthony Cucchi as the new Chapter President of AFEA’s Newton Square, PA Chapter. With the addition of Anthony Cucchi as the new Chapter President, AFEA is expanding its geographical footprint to cover
AFEA Welcomes New Chapter President
Leader in Financial Literacy Continues to Expand The American Financial Education Alliance is dedicated to providing financial education and increasing financial literacy within communities all over the country. Today, the Board of Directors has chosen to continue to do just that, by unanimously voting in Angelica Jones as the new Chapter President of AFEA’s Glendale, California Chapter. With the addition of Angelica Jones as the new Chapter President, AFEA is expanding
SPS/GZ to Present at the Chapter Meeting of the Chicago Chapter of the NASPP
Chicago, IL, October 20, 2010 -- Stock Plan Solutions/Green Zapato LLC (SPS/GZ), a leader in equity compensation administration and outsourcing today announced that Rick Zatz, CEP, will be presenting at the meeting of the Chicago Chapter of the NASPP in October 27, 2010. The U.S. Treasury Department issued the final regulations relating to the return information statement requirements under IRC 6039. These regulations impose return and information statement reporting requirements on